Abstract 4007

  • Post author:
  • Post category:boa

Abstract 4007 Hepatic arterial infusion chemotherapy of oxaliplatin plus fluorouracil versus sorafenib in advanced hepatocellular carcinoma: A biomolecular exploratory, randomized, phase 3 trial (The FOHAIC-1 study). Ning Lyu, Ming Zhao…

Continue ReadingAbstract 4007

Abstract 4006

  • Post author:
  • Post category:boa

Abstract 4006 Liposomal irinotecan (nal-IRI) in combination with fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic biliary tract cancer (BTC) after progression on gemcitabine plus cisplatin (GemCis): Multicenter comparative…

Continue ReadingAbstract 4006

Abstract 1003

  • Post author:
  • Post category:boa

Abstract 1003 Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial. Zhongyu Yuan, Jia-Jia Huang, Xin…

Continue ReadingAbstract 1003

Abstract 1002

  • Post author:
  • Post category:boa

Abstract 1002 Dalpiciclib versus placebo plus fulvestrant in HR+/HER2- advanced breast cancer that relapsed or progressed on previous endocrine therapy (DAWNA-1): A multicenter, randomized, phase 3 study. Binghe Xu, Qingyuan…

Continue ReadingAbstract 1002

Abstract 12010

  • Post author:
  • Post category:boa

Abstract 12010 The effects of geriatric assessment on oncologist-patient communication regarding functional status and physical performance in older adults with cancer: A secondary analysis of a 541-subject nationwide URCC NCORP…

Continue ReadingAbstract 12010

Abstract 12003

  • Post author:
  • Post category:boa

Abstract 12003 Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11. Vered Stearns, Opeyemi Jegede, Victor Tsu-Shih Chang, Todd…

Continue ReadingAbstract 12003

Abstract 9502

  • Post author:
  • Post category:boa

Abstract 9502 Neoadjuvant and adjuvant nivolumab (nivo) with anti-LAG3 antibody relatlimab (rela) for patients (pts) with resectable clinical stage III melanoma. Rodabe Navroze Amaria, Michael A. Postow, Michael T. Tetzlaff,…

Continue ReadingAbstract 9502

Abstract 9503

  • Post author:
  • Post category:boa

Abstract 9503 Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224-047). ​ Evan J. Lipson, Hussein Abdul-Hassan Tawbi, Dirk Schadendorf, Paolo…

Continue ReadingAbstract 9503

Takeda

  • Post author:
  • Post category:boa

Takeda https://demo.annual-meeting.in.th/wp-content/uploads/2021/07/Doctor-Consulting-With-A-Patient-Sample-Video.mp4

Continue ReadingTakeda

Stada

  • Post author:
  • Post category:boa

Stada https://demo.annual-meeting.in.th/wp-content/uploads/2021/07/Doctor-Consulting-With-A-Patient-Sample-Video.mp4 สอบถามข้อมูลเพิ่มเติมได้ที่Line OA STADA Thailand https://demo.annual-meeting.in.th/wp-content/uploads/2021/07/Doctor-Consulting-With-A-Patient-Sample-Video.mp4

Continue ReadingStada